Dnavec Research Inc.
Records under this name other than patents Dnavec Research Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,741,650 | Methods for producing minus-strand RNA viral vectors using hybrid promoter comprising cytomegalovirus enhancer and chicken β-actin promoter Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 7,402,427 | Vectors with modified protease-dependent tropism Term ended Term ended Mar 9, 2024 · From the USPTO record | Term ended | Term ended Mar 9, 2024 | From the USPTO record |
| US 8,889,118 | Anticancer agent containing dendritic cell having RNA virus transferred thereinto Lapsed on the fee record Ended Nov 18, 2022 · From the USPTO record | Lapsed on the fee record | Ended Nov 18, 2022 | From the USPTO record |
| US 7,709,621 | Vectors with modified protease-dependent tropism Lapsed on the fee record Ended May 4, 2022 · From the USPTO record | Lapsed on the fee record | Ended May 4, 2022 | From the USPTO record |
| US 7,510,706 | Pseudotype retroviral vectors containing membrane proteins having hemagglutinin activity Term ended Term ended Mar 23, 2022 · From the USPTO record | Term ended | Term ended Mar 23, 2022 | From the USPTO record |
| US 8,211,868 | Paramyxovirus vector encoding angiogenesis gene and use thereof Term ended Term ended Nov 27, 2021 · From the USPTO record | Term ended | Term ended Nov 27, 2021 | From the USPTO record |
| US 8,217,019 | AIDS virus vaccines using Sendai virus vector Term ended Term ended Mar 30, 2021 · From the USPTO record | Term ended | Term ended Mar 30, 2021 | From the USPTO record |
| US 7,314,614 | Recombinant sendai virus vector for introducing exogenous genes to airway epithelia Term ended Ended no later than Nov 2, 2020 · From the USPTO record | Term ended | Ended no later than Nov 2, 2020 | From the USPTO record |
| US 7,226,786 | Envelope gene-deficient Paramyxovirus vector Lapsed on the fee record Ended Jun 5, 2019 · From the USPTO record | Lapsed on the fee record | Ended Jun 5, 2019 | From the USPTO record |
| US 7,442,544 | Recombinant sendai virus Term ended Term ended Oct 17, 2017 · From the USPTO record | Term ended | Term ended Oct 17, 2017 | From the USPTO record |